Real-time · AI · Cross-signal
Jeffrey Young just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Jeffrey Young's next role move, new team, and the deals that follow. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now
Only Fundz delivers all four.
Paratus Sciences Appoints Alicia Secor As Chief Executive Officer and Jeffrey Young As Chief Financial Officer
PRIVATEApr 22, 2026•about 1 month ago
Position
Chief Financial Officer
Company
Paratus Sciences
BiotechnologyHealth CareArtificial IntelligenceTherapeutics
Description
Paratus Sciences has announced the appointment of Alicia Secor as President and Chief Executive Officer, along with Jeffrey Young as Chief Financial Officer. These appointments are part of a strategy to enhance the leadership team and advance their therapeutic candidate PS-1001 towards first-in-human studies.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months